• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌患者血清癌胚抗原、糖类抗原19-9及糖类抗原72-4的差异与相关性

Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer.

作者信息

Yu Junxiu, Zhang Shuguang, Zhao Bingbo

机构信息

Department of Gastrointestinal Surgery, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong 252000, P.R. China.

Laboratory Department, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong 252000, P.R. China.

出版信息

Mol Clin Oncol. 2016 Mar;4(3):441-449. doi: 10.3892/mco.2015.712. Epub 2015 Dec 15.

DOI:10.3892/mco.2015.712
PMID:26998301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4774443/
Abstract

The sensitivity of three biomarkers, carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9 and CA72-4, in combination has been identified to be greater than that of any of the biomarkers considered in isolation in cases of gastric cancer (GC). However, the fundamental cause underlying this phenomenon remains to be fully elucidated. In the present study, the differences and correlation of these three biomarkers were investigated in patients with GC in order to determine how the three biomarkers in combination work more effectively compared with any of the biomarkers considered alone. The serum levels of CEA, CA19-9 and CA72-4 of 216 patients with gastric adenocarcinoma were analyzed on admission to hospital. The differences in positive rates and the serum levels of CEA, CA19-9 and CA72-4 were analyzed using the χ test and the non-parametric Wilcoxon two-sample test. Phi (f) correlation analysis was used to study the correlation among the expression (positive or not) levels of CEA, CA19-9 and CA72-4. The correlation among the serum levels of biomarkers was analyzed using Spearman's test. The results demonstrated that the combined positive rate of CEA, CA19-9 and CA72-4 was significantly higher compared with the individual CEA, CA19-9 and CA72-4 positive rates (44.91% vs. 22.69, 18.98 and 22.69%, respectively; all P<0.05). The positive rate of CA19-9 and CA72-4 in the extent of the primary tumor/involvement of regional lymph node/distant metastases (TNM)-III/IV stage subgroup was higher compared with that in the TNM-I/II subgroup (χ=5.902, P=0.015; χ=8.009, P=0.005), although not the positive rate of CEA (χ=0.302, P=0.583). A significant correlation was identified between the expression level of CEA and CA72-4 (f correlation coefficient=0.182; P=0.008) and between that of CA19-9 and CA72-4 (f correlation coefficient=0.189; P=0.006), although not between that of CEA and CA19-9 (f correlation coefficient=0.048; P=0.482) in the total number of patients with GC. A significant correlation was also identified between the serum levels of CEA and CA19-9, of CEA and CA72-4 and of CA19-9 and CA72-4 (Spearman's correlation coefficient=0.231, -0.271 and 0.167; P=0.001, P<0.0001 and P=0.014, respectively). The present study indicated that there was only a weak correlation between the positive rate of CEA and CA72-4 and between that of CA19-9 and CA72-4, and no correlation was identified between the positive rate of CEA and CA19-9, even if a correlation was identified between the serum levels of the biomarkers. The present study suggested that the evidence that the sensitivity of the three biomarkers in combination is greater than that of any of the biomarkers taken in isolation is due to less co-presentation of CEA, CA19-9 and CA72-4 in patients with GC.

摘要

在胃癌(GC)病例中,癌胚抗原(CEA)、糖类抗原(CA)19 - 9和CA72 - 4这三种生物标志物联合检测的敏感性已被证实高于单独检测任何一种生物标志物。然而,这一现象背后的根本原因仍有待充分阐明。在本研究中,对GC患者的这三种生物标志物的差异及相关性进行了调查,以确定这三种生物标志物联合使用时相比单独使用任何一种生物标志物如何更有效地发挥作用。对216例胃腺癌患者入院时的血清CEA、CA19 - 9和CA72 - 4水平进行了分析。采用χ检验和非参数Wilcoxon两样本检验分析CEA、CA19 - 9和CA72 - 4的阳性率及血清水平差异。采用Phi(f)相关分析研究CEA、CA19 - 9和CA72 - 4表达水平(阳性或阴性)之间的相关性。采用Spearman检验分析生物标志物血清水平之间的相关性。结果表明,CEA、CA19 - 9和CA72 - 4联合阳性率显著高于单独的CEA、CA19 - 9和CA72 - 4阳性率(分别为44.91% vs. 22.69%、18.98%和22.69%;均P<0.05)。在原发肿瘤范围/区域淋巴结受累/远处转移(TNM)-III/IV期亚组中,CA19 - 9和CA72 - 4的阳性率高于TNM - I/II亚组(χ = 5.902,P = 0.015;χ = 8.009,P = 0.005),而CEA的阳性率并非如此(χ = 0.302,P = 0.583)。在所有GC患者中,CEA与CA72 - 4的表达水平之间(f相关系数 = 0.182;P = 0.008)以及CA19 - 9与CA72 - 4的表达水平之间(f相关系数 = 0.189;P = 0.006)存在显著相关性,而CEA与CA19 - 9的表达水平之间(f相关系数 = 0.048;P = 0.482)无显著相关性。CEA与CA19 - 9、CEA与CA72 - 4以及CA19 - 9与CA72 - 4的血清水平之间也存在显著相关性(Spearman相关系数分别为0.231、 - 0.271和0.167;P = = 0.001、P<0.0001和P = 0.014)。本研究表明,即使生物标志物的血清水平之间存在相关性,但CEA与CA72 - 4的阳性率之间以及CA19 - 9与CA72 - 4的阳性率之间仅存在弱相关性,CEA与CA19 - 9的阳性率之间无相关性。本研究提示,三种生物标志物联合检测的敏感性高于单独检测任何一种生物标志物,其原因在于GC患者中CEA、CA19 - 9和CA72 - 4的共同出现较少。

相似文献

1
Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer.胃癌患者血清癌胚抗原、糖类抗原19-9及糖类抗原72-4的差异与相关性
Mol Clin Oncol. 2016 Mar;4(3):441-449. doi: 10.3892/mco.2015.712. Epub 2015 Dec 15.
2
Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.胃癌患者肿瘤标志物的临床评估与预后评价。
Int J Biol Markers. 2013 Jun 28;28(2):192-200. doi: 10.5301/jbm.5000023.
3
Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.血清癌胚抗原、糖类抗原72-4、糖类抗原19-9、糖类抗原15-3和糖类抗原12-5联合检测在胃癌诊断中的价值
Ann Clin Lab Sci. 2017 May;47(3):260-263.
4
[Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer].血清癌胚抗原、糖类抗原19-9、糖类抗原72-4及糖类抗原242在胃癌诊断及预后中的临床价值
Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Feb;15(2):161-4.
5
Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.血清癌胚抗原、糖类抗原72-4、糖类抗原19-9及肿瘤特异性生长因子联合检测在胃癌诊断中的价值
Asian Pac J Cancer Prev. 2015;16(9):3867-70. doi: 10.7314/apjcp.2015.16.9.3867.
6
The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.癌胚抗原、CA19.9和CA72.4的血清及胃液水平在胃癌患者中的作用
J Cancer Res Clin Oncol. 1998;124(8):450-5. doi: 10.1007/s004320050198.
7
Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.胃癌患者中CA72-4与CEA和CA19-9相比的临床意义及预后价值
Dis Markers. 2000;16(3-4):105-10. doi: 10.1155/2000/595492.
8
Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer.血清癌胚抗原、糖类抗原19-9及糖类抗原72-4在胃癌患者中的临床意义及诊断价值
Oncotarget. 2016 Aug 2;7(31):49565-49573. doi: 10.18632/oncotarget.10391.
9
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.评估血清 CEA、CA19-9、CA72-4、CA125 和铁蛋白作为结直肠癌的诊断标志物和临床参数的影响因素。
Sci Rep. 2018 Feb 9;8(1):2732. doi: 10.1038/s41598-018-21048-y.
10
Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.用于上消化道癌患者诊断、复发监测及预后评估的肿瘤标志物。
Asian Pac J Cancer Prev. 2014;15(23):10267-72. doi: 10.7314/apjcp.2014.15.23.10267.

引用本文的文献

1
[GPSM2 is highly expressed in gastric cancer to affect patient prognosis by promoting tumor cell proliferation].[GPSM2在胃癌中高表达,通过促进肿瘤细胞增殖影响患者预后]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Feb 20;45(2):229-238. doi: 10.12122/j.issn.1673-4254.2025.02.03.
2
Dysregulated transfer RNA-derived small RNAs as potential gastric cancer biomarkers.失调的转运RNA衍生小RNA作为潜在的胃癌生物标志物
Exp Biol Med (Maywood). 2024 Dec 13;249:10170. doi: 10.3389/ebm.2024.10170. eCollection 2024.
3
Serum tumor markers (carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4, carbohydrate antigen 24-2, ferritin) and gastric cancer prognosis correlation.血清肿瘤标志物(癌胚抗原、糖类抗原19-9、糖类抗原72-4、糖类抗原24-2、铁蛋白)与胃癌预后的相关性。
World J Gastrointest Surg. 2024 Sep 27;16(9):2808-2814. doi: 10.4240/wjgs.v16.i9.2808.
4
The utilization of blood serum ATR-FTIR spectroscopy for the identification of gastric cancer.利用血清衰减全反射傅里叶变换红外光谱法鉴定胃癌。
Discov Oncol. 2024 Aug 14;15(1):350. doi: 10.1007/s12672-024-01231-6.
5
Determination of serum CA724 levels using fluorescence immunochromatography.采用荧光免疫层析法测定血清 CA724 水平。
BMC Biotechnol. 2023 Aug 18;23(1):30. doi: 10.1186/s12896-023-00801-w.
6
Capitalizing glycomic changes for improved biomarker-based cancer diagnostics.利用糖组学变化改进基于生物标志物的癌症诊断
Explor Target Antitumor Ther. 2023;4(3):366-395. doi: 10.37349/etat.2023.00140. Epub 2023 Jun 28.
7
The importance of CA 72-4 and CA 19-9 dosing in gastric cancer.CA 72-4 和 CA 19-9 剂量在胃癌中的重要性。
J Med Life. 2023 Feb;16(2):186-188. doi: 10.25122/jml-2022-0173.
8
Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer.鸟氨酸转氨酶和氨甲酰磷酸合成酶 1 参与氨代谢,可作为胃癌早期阶段的新靶点。
J Clin Lab Anal. 2022 Oct;36(10):e24692. doi: 10.1002/jcla.24692. Epub 2022 Sep 13.
9
tRNA-derived fragments in gastric cancer: Biomarkers and functions.胃癌中的 tRNA 衍生片段:生物标志物和功能。
J Cell Mol Med. 2022 Sep;26(18):4768-4780. doi: 10.1111/jcmm.17511. Epub 2022 Aug 11.
10
Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study.多种肿瘤标志物与新诊断胃癌患者的相关性:一项回顾性研究。
PeerJ. 2022 May 19;10:e13488. doi: 10.7717/peerj.13488. eCollection 2022.

本文引用的文献

1
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
2
Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer.联合检测癌胚抗原、糖类抗原19-9、糖类抗原242和糖类抗原50在可切除胃癌诊断及预后评估中的应用
Asian Pac J Cancer Prev. 2014;15(15):6295-300. doi: 10.7314/apjcp.2014.15.15.6295.
3
CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.CA72-4联合癌胚抗原(CEA)、糖类抗原125(CA125)和糖类抗原19-9(CA19-9)可提高胃癌早期诊断的敏感性。
Clin Chim Acta. 2014 Nov 1;437:183-6. doi: 10.1016/j.cca.2014.07.034. Epub 2014 Jul 30.
4
At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? Application in advanced gastric cancer treatment.癌胚抗原和糖类抗原 19-9 水平在胃癌进展的哪个阶段升高?在晚期胃癌治疗中的应用。
J Gastric Cancer. 2014 Jun;14(2):123-8. doi: 10.5230/jgc.2014.14.2.123. Epub 2014 Jun 30.
5
Identification of prognostic factors and surgical indications for metastatic gastric cancer.转移性胃癌预后因素及手术指征的识别
BMC Cancer. 2014 Jun 6;14:409. doi: 10.1186/1471-2407-14-409.
6
Clinicopathological features of CA19-9-producing gastric cancer.产生CA19-9的胃癌的临床病理特征
Hepatogastroenterology. 2014 Jan-Feb;61(129):221-5.
7
Prognostic value of preoperative serum tumor markers in gastric cancer.术前血清肿瘤标志物在胃癌中的预后价值
World J Clin Oncol. 2014 May 10;5(2):170-6. doi: 10.5306/wjco.v5.i2.170.
8
Clinical characteristics and outcomes for gastric cancer patients aged 18-30 years.18至30岁胃癌患者的临床特征与结局
Gastric Cancer. 2014 Oct;17(4):649-60. doi: 10.1007/s10120-013-0331-1. Epub 2014 Jan 11.
9
Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis).CEA 和 CA19-9 单独及联合检测在食管癌、胃癌和结肠癌中的对比研究(ROC 曲线分析)。
Cancer Biol Med. 2013 Sep;10(3):148-57. doi: 10.7497/j.issn.2095-3941.2013.03.005.
10
Clinical utility of tumor marker cutoff ratio and a combination scoring system of preoperative carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4 levels in gastric cancer.肿瘤标志物截断值比率及术前癌胚抗原、糖类抗原19-9、糖类抗原72-4水平联合评分系统在胃癌中的临床应用价值
J Korean Surg Soc. 2013 Dec;85(6):283-9. doi: 10.4174/jkss.2013.85.6.283. Epub 2013 Nov 26.